About this trial
The goal of this clinical study is to evaluate whether AI-based customized transcranial direct current stimulation (tDCS) using MR images is more effective than sham stimulation in improving finger motor function in patients with finger paralysis caused by subacute stroke. The main questions it aims to answer are:
* Does AI-based customized tDCS improve finger motor function compared with sham stimulation? * What medical problems or adverse events occur when participants receive AI-based customized tDCS?
Researchers will compare AI-based customized tDCS with sham stimulation (a look-alike stimulation that delivers no electrical current) to determine whether the intervention improves finger motor recovery in patients with subacute stroke.
Eligibility criteria
Qualifiers
Adults aged 19 years or older
Patients with stroke confirmed by brain imaging
Subacute stroke patients within 2 weeks to 3 months after stroke onset
Patients with unilateral upper-extremity paralysis
Disqualifiers
History of a condition affecting the function of the paralyzed arm
Inability to follow instructions or complete the study due to cognitive impairment or aphasia
Evidence of delirium, confusion, or other disorders of consciousness
Presence of uncontrolled medical or surgical conditions
Trial design
Treatments tested in this trial
- AI-based Customized transcranial Direct Current Stimulation
- Sham transcranial Direct Current Stimulation
Treatment groups
Sponsors and collaborators
NEUROPHET
Lead sponsor
Severance Hospital
Collaborator
Asan Medical Center
Collaborator
Bucheon St. Mary's Hospital
Collaborator
Samsung Medical Center
Collaborator
National Rehabilitation Center, Seoul, Korea
Collaborator
National Health Insurance Service Ilsan Hospital
Collaborator